You are here

Interview with Florian Strasser at ECC 2015: New and exciting interventions for cancer cachexia

rc_qol_strasser_720p

Almost all patients with advanced cancer have some level of cachexia, leading to fatigue, loss of muscle function, distress and increased toxicity of cancer treatments. As a result, cachexia reduces survival.

At the European Cancer Congress (Vienna, Austria; 25 – 29 September 2015), Dr Florian Strasser (Cantonal Hospital St. Gallen, Switzerland) said that current approaches are unsatisfactory. Drugs such as corticosteroids do not help long term, attempts to increase nutrition tend to be unsuccessful and management of the condition is often fragmented.

This may be set to change, he tells journalist Helen Saul in this video. Better understanding of the underlying mechanisms means there are several new drugs close to registration, and a new drive towards integrated management of the condition could make a real difference in the near future.  

Search this site

Featured videos

Free access to ebooks on cachexia and CINV

 

Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

and
Cancer cachexia: mechanisms and progress in treatment

 

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo

Share